SOAN 8k out As of February 4, 2021, the Company amended and restated its Exclusive Global Multiple Sclerosis License Agreement to give both parties a stronger and more robust platform to move synergistically forward to market and license U.S. patent 10,610,592 issued to Fabrizio de Silvestri, Terni, Italy, as inventor, April 7, 2020. https://www.sec.gov/Archives/edgar/data/15021...rm_8-k.htm